share_log

Takeda Pharmaceutical | 6-K: The 147th (interim period) Business Report

SEC announcement ·  Nov 30, 2023 06:01
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more